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Department of Human Genetics, University Hospital of Ulm, Ulm, Germany
The major causes of fragile X syndrome are mutational expansion of the CGG repeat in the FMR1 gene, hyper-
methylation, and transcriptional silencing. Most fragile X embryos develop somatic mosaicism of disease-causing
“full” expansions of different lengths. Homogeneity of the mosaic patterns among multiple tissues in the same
individual indicates that these previously unstable expansions acquire mitotic stability early in fetal life. Since mitotic
stability is found strictly associated with hypermethylation in adult tissues, current theory has fixed the time of
instability to developmental stages when fully expanded CGG repeats exist in an unmethylated state. We used
murine embryocarcinoma (EC) cells (PC13) as a model system of pluripotent embryonic cells. Hypermethylated
and unmethylated full expansions on human fragile X chromosomes were transferred from murine A9 hybrids into
EC cells, by means of microcell fusion. As demonstrated in the present study for the first time, even full expansion
alleles that were fully methylated and stable in the donors’ fibroblasts and in A9 became demethylated, reactivated,
and destabilized in undifferentiated EC hybrids. When destabilized expansions were reintroduced from EC cells
into A9, instability was reversed to stability. Our results strongly support the idea that fully expanded alleles are
initially unstable and unmethylated in the human embryo and gain stability upon genetic or epigenetic change of
the embryonic cells.
Introduction
Fragile X syndrome [MIM 309550] is a paradigm of
a human genetic disease caused by expansion of an
unstable trinucleotide repeat; it is a frequent cause of
inherited mental retardation and the first disorder iden-
tified to result from this previously unknown type of
“dynamic” mutation (Imbert et al. 1998; Jin and War-
ren 2000). The unstable DNA sequence of tandemly
repeated CGGs is situated in the 5′ untranslated region
of the fragile X mental retardation gene (FMR1
[GenBank accession number XM_10288]; Verkerk et
al. 1991; Yu et al. 1991). Normal alleles usually contain
29 or 30 trinucleotides. Repeat sizes of 60–200 tri-
nucleotides characterize “premutation” alleles, which
are carried by unaffected males and females transmit-
ting the trait. Large disease-causing expansions occur
only upon transmission by a carrier mother (Fu et al.
1991; Imbert et al. 1998). These “full-mutation” alleles
include 220 CGGs, but expansion size may reach
1,000 triplets. Full expansion usually coincides with
excessive de novo hypermethylation spreading partic-
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ularly over the large CGG repeat (Oberle´ et al. 1991;
Hornstra et al. 1993) and the FMR1 promoter region
(Drouin et al. 1997; Schwemmle et al. 1997). Fully
expanded alleles, very exceptionally, remain unmeth-
ylated, for an unknown reason. On the basis of psy-
chometric testing, males carrying such “unmethylated
full mutations” are classified as “high functioning”
(Hagerman 1998); some of them may even be physi-
cally and intellectually unaffected (Wo¨hrle et al. 1998).
The hypermethylated state of the fragile X full mu-
tation is found associated locally with histone deacet-
ylation and chromatin remodeling (Coffee et al. 1999),
with late DNA replication, and with transcriptional si-
lence of the gene (Imbert et al. 1998). The latter results
in loss of the FMR1 protein product, FMRP, thereby
obviously causing the fragile X phenotype.
In all somatic human cells that have been studied so
far, hypermethylation also coincides with mitotic sta-
bility of the repeat (Steinbach et al. 1998), despite the
fact that repeat size is far beyond the threshold at which
all types of triplet repeats become prone to experience
large changes in their triplet numbers upon each single
round of DNA replication (McMurray 1999). At least
three lines of evidence substantiate an absolute associ-
ation between hypermethylation and repeat stability in
fragile X patients:
1. Patterns of hypermethylated expansions show sub-
stantial homogeneity of repeat sizes among differ-
ent tissues of fetuses with fragile X (Devys et al.
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1992; Wo¨hrle et al. 1992) and among MZ twins
with fragile X who shared circulation at embryo-
genesis (Devys et al. 1992). Unmethylated triplet-
repeat expansions, on the other hand, were found
to show marked size heterogeneity among different
tissues of individuals with fragile X (Taylor et al.
1999) and of individuals with myotonic dystrophy
(Wo¨hrle et al. 1995).
2. Cloning by dilution plating of fibroblasts from pa-
tients with fragile X who present a mosaic pattern
of different methylated full expansions results in
the isolation of “discrete-length” alleles, thereby
showing that the length of methylated expansions
is stably maintained in a clonal fashion (Wo¨hrle et
al. 1993). When similar experiments were per-
formed with fibroblasts from a male with fragile X
who had unmethylated full expansions, the clonal
cell DNA samples showed multiple allele sizes with
smearing of expansion patterns, a pattern that is
very consistent with repeat instability during clonal
cell proliferation (Gla¨ser et al. 1999).
3. When populations of cells with methylated full mu-
tations of different allele sizes were grown to high
numbers of population doublings, the pattern of
expansions did not change significantly (Wo¨hrle et
al. 1993, 1995); however, extensive changes in het-
erogeneous expansion patterns resulted upon con-
tinual proliferation of cells with unmethylated frag-
ile X full-mutation alleles (Gla¨ser et al. 1999; Salat
et al. 2000). Unmethylated CTG repeat expansions
in the DMPK gene of myotonic dystrophy experi-
enced significant further expansion, which occurred
with ongoing cell proliferation in vitro (Wo¨hrle et
al. 1995).
An absolute association between mitotic stability and
the hypermethylated state of the expanded allele has
been found in differentiated somatic cells of fetuses and
adults with fragile X, but whether this association exists
in any other type of cells remains to be elucidated. Two
cell types are of particular interest: somatic cell hybrids
and undifferentiated embryonic cells.
Somatic cell hybrids, constructed by fusion between
human fibroblasts and immortalized rodent cells, have
been studied elsewhere, but the findings have been con-
tradictory. When the human donor fibroblasts carried
fully methylated full-mutation alleles, the majority of
the resulting hybrid clones were reported to harbor a
fully methylated and mitotically stable allele (Steinbach
et al. 1998); however, examples of fully methylated but
mitotically unstable fragile X expansions have also been
reported (Burman et al. 1999). When unmethylated and
mitotically unstable full-mutation alleles were intro-
duced into the background of murine host cell lines,
some—but not all—of the hybrid clones harbored a
single unmethylated expansion that retained its unstable
mitotic behavior (Gla¨ser et al. 1999). Given these con-
tradictory results, we decided to study the behavior of
expanded fragile X repeats in murine host cells in more
detail.
Undifferentiated cells of embryonic origin represent
a model system for investigation of the behavior of frag-
ile X expansions during early embryonic development.
Somatic mosaicism is found in the vast majority of full-
mutation patients (Rousseau et al. 1994), in contrast to
the mitotic stability of methylated expansions and the
homogeneity in expansion size among different tissues
of fetuses with fragile X (Devys et al. 1992; Wo¨hrle et
al. 1992). Thus, there is strong, albeit indirect, evidence
that expanded alleles are mitotically unstable at a very
early developmental stage, during mitotic proliferation
of embryonic cells that are undifferentiated, if not plu-
ripotent. One outstanding question is whether, in these
early embryonic cells, the unstable expansions are de-
methylated and become stabilized at embryonic cell dif-
ferentiation and de novo methylation. In the present
study, we investigate human fragile X–mutation alleles
transferred into mouse embryocarcinoma (EC) cells
PC13 (Hooper and Slack 1977), by means of microcell-
mediated chromosome transfer (Fournier 1981). This
enabled us to actually demonstrate, for the first time,
the demethylation and reactivation of previously hy-
permethylated full-mutation alleles and, in particular,
their destabilization in the background of embryonic
cells.
Material and Methods
Cell Lines and Cell Culture
Human fibroblast cultures were established from skin
biopsies from a young boy (ML) with fragile X, who
was carrying a full mutation that was fully methylated,
and an apparently unaffected male (GZ) with fragile X,
who presented pre- and full-mutation alleles that were
fully unmethylated, with the exception of a few cellswith
a methylated allele. Details of the latter case have been
reported elsewhere (Wo¨hrle et al. 1998; Salat et al.
2000). The fibroblasts were maintained in Dulbecco’s
modified Eagle’s medium (DMEM), following standard
protocols.
The mouse EC cell line PC13TG8, a hypoxanthine
phosphoribosyltransferase (HPRT)–deficient derivative
of PC13, was a generous gift from M. L. Hooper of the
University of Edinburgh and has been characterized in
detail by Hooper and Slack (1977). In spite of their
capacity for unlimited growth and their malignant prop-
erties in an abnormal environment, PC13 are embryonic
cells shown to retain their developmental capacities after
many generations of growth in vitro, behaving in a man-
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ner indistinguishable from that of normal embryonic
cells when placed into a blastocyst (Hooper and Slack
1977). PC13 and PC13TG8 show the same pattern of
predominant neural differentiation.
The EC cells were cultured on gelatinized plastic sur-
faces (0.2% gelatin, Sigma) without feeders and were
maintained in DMEM supplemented with nonessential
amino acids (GIBCO), 2 mM glutamine, 15% FCS, 0.1
mMmonothioglycerol, 100 U/l penicillin, 100 mg/l strep-
tomycin, and recombinant leukemia inhibitory factor in
concentrations appropriate for the inhibition of spon-
taneous differentiation of embryonic stem cells. This me-
dium is referred to as “ES-cell medium.”
Whole-Cell Fusion and Microcell-Mediated
Chromosome Transfer
Human fragile X chromosomes were transferred to
HPRT-deficient mouse A9 cells—which are known to
make good microcell donors—by polyethylene glycol
(PEG)–mediated fusion with human fibroblasts as de-
scribed elsewhere (Gla¨ser et al. 1999). Hybrid cells were
grown in DMEM plus 0.1 mM hypoxanthine, 0.4 mM
aminopterine, and 0.016 mM thymidine (HAT, Sigma)
plus 0.05 mM Ouabain (Sigma). Clones were isolated
12–18 d after initiating selection, expanded in HAT-con-
taining medium, harvested for DNA analysis, and cryo-
preserved in DMEM plus 10% dimethylsulfoxide (Sig-
ma). Subclones were generated from parental hybrid
clones by means of dilution plating, and were selected,
expanded, and harvested for DNA analysis and cryo-
preservation.
Microcell-mediated transfer of fragile X chromosomes
from whole-cell A9 hybrid clones into PC13TG8 recip-
ient cells was performed essentially as described by Four-
nier (1981). In brief, donor cells were split onto bullet-
shaped plastic slides, allowed to recover for 24 h in
HAT-containing medium, and treated with 0.05 mg/ml
colcemid (Sigma) for 48 h. Micronucleation was per-
formed using 10 mg/ml cytochalasin B (Sigma). Micro-
cells were attached to recipient cells by 100 mg/ml phy-
tohemagglutinin (PHA-P, Sigma) and were fused with
44% weight/volume PEG 1500 (Boehringer). Hybrid
cells were allowed to recover overnight and were then
split 1:3 into HAT-containing ES-cell medium. Clones
were isolated after 14–21 d and were independently an-
alyzed. Human FMR1 alleles harbored in hybrid cells
were detected by PCR amplification of exon 4, as de-
scribed elsewhere (Eichler et al. 1993).
Microcell-mediated transfer of fragile X chromosomes
from PC13 hybrids into A9 recipient cells was performed
essentially as described above. Hybrid cells were treated
with 0.05-mg/ml colcemid for 24–48 h. Cells were then
transferred to Con-A–treated bullets (Islam and Islam
2000) and were allowed to attach for 90 min before
micronucleation. To identify hybrids of PC13 and A9
that contained chromosomes of both murine parents,
the murine markers Mt3pAB (chromosome 8) and
GA12 (chromosome 12) were typed using PCR prim-
ers provided by the Jackson Laboratory.
DNA Analysis
Genomic DNA was isolated from cultured cells by salt
extraction (Miller et al. 1988). Aliquots (20 mg) were
cleaved with restriction endonucleases EcoRI plus EagI
or PstI, size-separated by electrophoresis through 0.8%
agarose gels, blotted on a positively charged nylon
membrane, and hybridized to a[32P]-dCTP oligolabeled
probes Ox1.9 or Ox0.55, as described elsewhere (Wo¨hrle
et al. 1993). Expansion size was measured as the CGG-
repeat index, calculated by dividing the difference in size
(in bp) between the normal and mutant bands by 3 and
adding 30, which is the most common CGG-repeat num-
ber of normal alleles in the German population.
Sodium Bisulfite Conversion and Analysis of FMR1-
Promoter Methylation
Bisulfite conversion, PCR, and DNA sequencing were
performed as described elsewhere (Salat et al. 2000).
Nested PCR was performed with primer pair 1F/1R,
followed by M13-2F/M13-2R, designed to amplify bi-
sulfite-converted DNA (upper strand) of the FMR1 pro-
moter (Schwemmle et al. 1997). The primer sequences
were as follows: 5′-TGAGTGTAT TTT TGTAGAAAT
GGG C/T G-3′ (1F), 5′-CTC AAA AAC A/G AC CCT
CCA CC A/G-3′ (1R), 5′-GGT AAC GCC AGG GGT
TTC CGG TTT TC/TG C/TGA GGT AGT GTG ACT
AAA ACC-3′ (M13-2F), 5′-GAA ACA GCT ATG ACC
ATG A/G AA ACT AAA C A/G C CTA ACTAAAACC-
3′ (M13-2R). Products of the second PCR were purified
through an agarose gel, followed by gel extraction
through use of a QIAquick gel extraction kit (Qiagen)
and sequencing on an ABI 377 Prism (Applied Biosys-
tems) using fluorescent sequencing technology. For each
experiment, all examined non-CpG cytosine residues
were detected as T residues, indicating complete bisulfite
conversion of the analyzed DNA fragments.
RT-PCR
Total RNA, isolated from cultured cells by means of
the RNeasy mini kit (Qiagen), was treated with DNAse
and reverse transcribed through use of the GeneAmp
RNA-PCR Kit (Perkin-Elmer), following the manufac-
turers instructions. PCR primers were 5′-TTG AAT TTT
CAT TTT ACA G-3′ (HuSp1) and 5′-CCT TGG TTA
ATT ATC TAC A-3′ (HuSp2) for the human FMR1 al-
lele, and 5′-AGA TGT TTT CAG CTA CTT G-3′
(MuSp1) and 5′-AAA AAA ACC CCA CAA AAA T-3′
(MuSp2) for the murine allele. These primer pairs bind
to the 3′ untranslated region and were designed by R.
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Figure 1 Southern analysis of fragile X expansions harbored in murine A9 host cells. DNA samples isolated from fibroblasts of donors
(ML and GZ) and from A9 hybrid clones were cleaved by restriction enzyme and hybridized to probe Ox1.9. A, Discrete-length alleles of
methylated full expansions were isolated into different hybrid clones. DNA samples were cleaved with EcoRI plus EagI. The results for the
donor’s (ML) fibroblasts and for six hybrid clones are shown with the clone numbers indicated. Because of methylation of the EagI site in the
FMR1 promoter, the expanded fragments are larger than the normal 5.2-kb fragment seen in the control (lane C). Clone 32* was selected for
microcell generation. B and C, Unmethylated expansions isolated into A9 hybrid clones (numbers shown above the lanes) and visualized by
hybridization to EcoRI-plus-EagI–cleaved DNA. Cleavage of unmethylated EagI sites of expanded alleles results in fragments between 2.8 and
5.2 kb. Unmethylated 2.8-kb and methylated 5.2-kb-fragments are carried on the active and inactive X chromosomes of the female control
(lane C). Whereas the donor’s (GZ) fibroblasts presented smears of multiple expansions, the majority of hybrids harbored a single expanded
fragment with unmethylated EagI site. Clones 18*, 35*, and 36* were used in further experiments. D and E, Mitotic stability of expansions
isolated from GZ into A9 clones 18 and 35 (GZA9.18, GZA9.35). Clonal DNAs were isolated at successive passages and cleaved withHindIII.
The passage numbers are given above the lanes in D and E; population doublings are three to four times the passage number. The HindIII
fragments of the murine gene, indicated by arrows (R), are seen inD and E above the human fragments carrying 330 and 230 CGGs, respectively.
Bauchwitz of Columbia University. Species-specific am-
plification was confirmed on numerous occasions, in-
cluding in the present study.
Results
Mitotic Stability in A9 Host Cells
To investigate the behavior of full-mutation alleles in
mouse host cells, human fragile X chromosomes bearing
methylated or unmethylated full expansions were intro-
duced into mouse A9 cells by means of whole-cell fusion
with primary human fibroblasts. Results are illustrated
in figure 1 and summarized in table 1.
The donor of methylated full expansions was an af-
fected male with fragile X (ML). His fibroblasts showed
fully methylated expansions and were completely neg-
ative for FMRP upon western analysis (Salat et al. 2000).
After fusion with A9 recipient cells, 34 hybrid clones
were isolated. Southern analysis of EcoRI-plus-EagI
cleaved clonal DNA revealed the presence of fully ex-
panded human FMR1 alleles in all hybrids, seen as a
sharp hybridization signal of a single expanded frag-
ment, with methylation of the EagI site maintained (fig.
1A).
The donor of unmethylated full expansions was an
apparently unaffected male with fragile X (GZ). As re-
ported elsewhere (Salat et al. 2000), these expanded al-
leles were mitotically unstable in proliferating fibro-
blasts. The primary culture used for this fusion ex-
periment showed multiple repeat expansions. Most of
them had 1300 CGGs, were unmethylated, and gave a
smeared pattern upon Southern analysis (fig. 1B, C).
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Table 1
Results from Southern Analysis of FMR1-Positive A9 Hybrid Clones
DONOR
NO. OF
CLONES
METHYLATION
STATUS OF
EagI SITE
NO. OF
EXPANSIONS
Single Extra
ML 34 Methylated 34 0
GZ 5 Methylated 4 1
GZ 34 Unmethylated 26 8
Total 73 64 9
NOTE.—The majority of hybrid clones contained single mitotically
stable expansions, regardless of EagI-site methylation status; however,
clones with extra expansions were significantly more frequent among
those harboring unmethylated FMR1 alleles ( , ).2x p 7.378 P ! .0066
Table 2
Hybrid Clones of A9 and PC13 Cells Harboring Human FMR1 Genes with Expanded CGG Repeats
DONOR
A9 EC
Clone Methylation Status (Harbored Alleles) Clone Methylation Status (Harbored Alleles)
GZ GZA9.18 Unmethylated (330 CGGs) GZEC21.4 Unmethylated (200, 240 CGGs, blurred)
GZEC21.1 Unmethylated (ND)
GZ GZA9.36 Unmethylated (215 CGGs) GZEC25.2 Unmethylated (ND)
GZ GZA9.35 Methylated* (230 CGGs) GZEC24.16 Demethylated (230 CGGs)
ML MLA9.32 Methylated (530 CGGs) MLEC30.1 Demethylated (110–570 CGGs, smear)
MLEC30.2 Demethylated (165 CGGs, smear)
NOTE.—Methylation status established upon sequencing of bisulfite-converted genomic DNA. Methylatedp fully meth-
ylated (i.e., all examined promoter CpGs methylated); Methylated* p partially methylated (i.e., all but three promoter
CpGs methylated); ND p repeat size not detected, and no signal obtained on Southern analysis.
Fragments with ∼230 CGGs, with a minority of them
methylated at the EagI site, were also detected. After
fusion with A9 cells, discrete-length alleles were found
separated into different hybrid clones. According to
Southern analysis, 34 of 39 clones harbored unmethyl-
ated alleles of different lengths, and 5 clones harbored
a methylated fragment with ∼230 CGGs (fig. 1B, C).
As summarized in table 1, 64 (88%) of 73 A9 hybrid
clones obtained fromML and GZ donor fibroblasts gave
one sharp expansion signal, indicating mitotic repeat
stability independent of the EagI sites’ methylation
status. Among the unmethylated full expansions from
GZ fibroblasts, 26 (76%) of 34 still gave a single sharp
signal in the clonal DNAs. To demonstrate mitotic sta-
bility directly, two hybrid clones derived from the cells
of GZ were analyzed at successive passages. Clone
GZA9.18 (fig. 1D) harbored an unmethylated expansion
of ∼320 CGGs, and clone GZA9.35 (fig. 1E) contained
a methylated 230-CGG fragment. Southern analysis
gave no evidence of any change in repeat size through
150 further doublings of both clonal cell populations.
Demethylation and Destabilization in Undifferentiated
PC13 EC Cells
To investigate the behavior of expanded fragile X re-
peats in undifferentiated embryonic cells, we usedmouse
EC cells derived from cell line PC13. Fragile X chro-
mosomes bearing methylated and unmethylated full
fragile X expansions were introduced by microcell fu-
sion. Microcells were generated from previously estab-
lished A9 hybrid clones harboring expanded FMR1 re-
peats that were mitotically stable. Fusion to recipient EC
cells resulted in a number of hybrid clones (table 2),
with a proportion of them harboring a human FMR1
allele, as revealed by PCR analysis. The EC hybrids re-
tained their undifferentiated morphology (fig. 2A, B)
that changed when differentiation was induced by ret-
inoic acid (fig. 2C, D). The hybrid cells then aggregated
to form embryoid bodies and subsequently acquired the
morphology of epitheloid and neuron-like cells.
Cytogenetic analysis was performed by whole-chro-
mosome painting of the human X chromosome on hy-
brid-cell metaphases. Mouse chromosomes were iden-
tified to carry a painted fragment of the human
X—apparently encompassing the HPRT and FMR1
loci—translocated to the mouse chromosome during
different events of interspecific chromosome rearrange-
ment (fig. 2E, F). During proliferation in selection me-
dium, most clones were prone to deletion of the human
FMR1 gene while retaining the active human HPRT
gene. The introduced human FMR1 gene was retained
in only one hybrid—MLEC30.1—after continual cell
proliferation.
Fragile X repeat expansions in EC hybrid clones were
analyzed on Southern blots of EcoRI-plus-EagI–cleaved
DNA, andmethylation of the promoter regionwas further
examined by sequencing of bisulfite-converted clonal
DNA. Results are illustrated in figure 3A and summarized
in table 2. Fusion of microcells fromGZA9.18, harboring
an unmethylated FMR1 allele with 330 CGGs, resulted
in two PC13 hybrid clones (GZEC21.1 and GZEC21.4),
which were shown to be FMR1-positive by PCR. Al-
though no fragile X expansions were visualized on South-
ern analysis of clone 21.1, careful inspection of X-rays
revealed a bipartite signal of two unmethylated expan-
sions (200 and 240 CGGs) in clone 21.4 (fig. 3A). This
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Figure 2 Morphology and cytogenetics of undifferentiated and differentiated EC hybrids of PC13 harboring human fragile X alleles. A,
Undifferentiated morphology of hybrid MLEC30.1. B, Undifferentiated morphology of a subclone isolated from MLEC30.1. C and D, Differ-
entiated morphology of hybrid MLEC30.1. Upon treatment with 1 mM retinoic acid, the cells aggregated to form embryoid bodies (EB) and,
subsequently, epitheloid (E) and neuron-like (N) cells. Bars p 100 mm. E and F, Mouse chromosomes harboring a fragment translocated from
a human fragile X chromosome, indicated by arrows (r), in MLEC30.1 (E) and GZEC25.2 (F). Metaphase chromosomes were prepared from
EC hybrids and analyzed by whole-chromosome painting of the human X chromosome with digoxigenin-labeled P5222-DG.5 (OncorAppligene).
finding suggested mitotic instability and contraction of
the transferred 330 CGG repeats to smaller alleles. Fusion
ofmicrocells fromGZA9.35 harboring an expandedallele
with 230 CGGs and a methylated EagI site resulted in
EC clone GZEC24.16 presenting an expanded FMR1
fragment of similar size, but with an unmethylated EagI
site. GZA9.36-derived microcells gave a single EC clone
(GZEC25.2) with a positive PCR result but with no ex-
pansion signal detectable on Southern analysis.
Transfer of the mitotically stable methylated 530-
CGG full-mutation allele of MLA9.32 into PC13 cells
resulted in FMR1-positive clones MLEC30.1 and
MLEC30.2 (table 2). Destabilization of the expanded
repeat and demethylation of the EagI site was evident
from Southern analysis of both clones (fig. 3A). Clone
30.1 harbored multiple expansions, with the demethyl-
ated EagI site giving a smear of hybridization signals of
110–570 CGGs. Most expanded fragments carried re-
peats of triplets. Clone 30.2 presented a smear530 35
of unmethylated expansions with a major signal at 165
CGGs.
Mitotic instability of expanded CGG repeats harbored
in EC hybrid clones was confirmed by subcloning of
MLEC30.1 (fig. 3B). Subclones retaining the human
gene showed no methylation of the EagI site. Half of
them gave hybridization signals of single expansions,
with repeat sizes of 30–285. The signals of the normal
and premutation-sized alleles (30–230 CGGs) were no-
tably sharp and intense, whereas those in the lower full-
mutation range (240–285 CGGs) had a diffuse appear-
ance on a PstI blot (fig. 3C). All the other subclones
demonstrated more-diffuse single-expansion signals or
broader smears of multiple expansions, with repeat sizes
ranging from large full mutations (430–650) down to
the premutation and normal sizes. This result clearly
indicates repeat instability occurring in the EC back-
ground, as a function of repeat size.
The methylation status of the FMR1-promoter region,
comprising the EagI site and a total of 29 CpG dinu-
cleotides clustered on a genomic fragment of 270 bp,
was also assessed by sequencing of bisulfite-converted
genomic DNA isolated from A9 and EC hybrid clones
(for details, see table 2). In striking contrast to the fully
methylated status of MLA9.32, the derivative EC clones
MLEC30.1 and MLEC30.2 had the FMR1 promoter
sequences fully demethylated.
Reactivation of Previously Inactive Full-Mutation
Alleles
EC and A9 hybrids were tested, by RT-PCR, for ex-
pression of human and mouse FMR1 mRNA (fig. 4).
Whereas murine FMR1 was expressed in all hybrids,
expression of the human alleles was correlated with the
methylation pattern of the FMR1 promoter.
The unmethylated full-mutation allele of hybrid
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Figure 3 Southern analysis of EC hybrids and their parental A9 clones. A, Lanes grouped such that each A9 clone is followed by its
derivative EC clone(s). Clonal DNAs were cleaved by EcoRI plus EagI. Fragments between 2.8 and 5.2 kb (see control lane C) represent
unmethylated alleles. Demethylation of previously methylated EagI sites is evident in GZEC24.16, MLEC30.1, and MLEC30.2. Repeat sizes
of all clones are given in table 2. B and C, MLEC30.1, subcloned by dilution plating, and subclonal DNAs, analyzed on EcoRI-plus-EagI (B)
and PstI blots (C). Results for 10 subclones are indicated by numbers above the lanes. Blurred and smeared signals consistent with mitotic
instability of subcloned expansions occurred as a function of repeat size.
GZA9.18 was transcribed and was also found to be
transcriptionally active in EC clone GZEC21.4. The par-
tially methylated 230-CGG FMR1 allele in GZA9.35
was almost completely inactive. When introduced into
clone GZEC24.16, where the allele was found to be
demethylated, it produced a much higher level of tran-
scripts. Hybrid MLA9.32 harbored a methylated full-
mutation allele with no transcripts detected by RT-PCR
analysis. When transferred to clones MLEC30.1 and
MLEC30.2, these alleles were demethylated and were
clearly transcribed in both EC hybrids. These findings
indicate stable transcriptional reactivation of previously
inactive fragile X full-mutation alleles associated with
demethylation in the background of undifferentiated em-
bryonic cells.
Regained Stabilization of Previously Destabilized
Expansions
To elucidate whether the destabilization of full fragile
X expansions that occurred in undifferentiated EC cells
could be reversed to stability in the background of dif-
ferentiated cells, expansions were retransferred from
clone MLEC30.1 to HPRT-deficient A9 cells, by means
of microcell fusion. When the microcells were generated,
the EC hybrid clone harbored multiple human FMR1
alleles with repeat sizes extending from ∼550 CGGs con-
tinuously down into the normal size range (fig. 5).
After microcell fusion, A9 clones ( ) were iso-np 58
lated, expanded, and tested, by PCR and Southern anal-
ysis. PCR tests of clonal DNAs identified 21 true hybrids
containing chromosomes of both murine parents, PC13
and A9, and the human FMR1 gene. The morphology
of these hybrids was typical of A9 cells and was signif-
icantly different from undifferentiated EC cells (fig. 5A)
Human FMR1 alleles were detected, by means of
Southern analysis, in each clone with the EagI sites still
unmethylated (fig. 5B). Discrete bands of normal and
premutation alleles were found in a few clones. The ma-
jority harbored full-mutation alleles with repeat sizes of
250–415. Smears of full expansions consistent with re-
peat instability were detected in a few exceptional clones.
Most clones presented with discrete fragments of full
expansions (250–415 CGGs), giving hybridization sig-
nals strongly suggesting mitotic stability that was, no-
tably, independent of repeat size. Subclones isolated
from one of the A9 hybrids (clone 16) with a single full
expansion (315 CGGs) again harbored single expan-
sions of the same size (fig. 5C), thereby confirming that
expansions previously destabilized in the EC hybrid re-
gained stability in the A9 background.
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Figure 4 Expression of human and murine FMR1 genes in EC hybrids of PC13 and their parental A9 clones. In the indicated cell lines
and in human control fibroblasts (lane C), expression of the human allele was visualized by human-specific RT-PCR (237-bp products).GZA9.18,
GZEC21.4, and the control cells carry unmethylated human FMR1 alleles (u). GZA9.35 and MLA9.32 harbor partially methylated (p) and
fully methylated (m) alleles that are demethylated (d) in GZEC24.16, which is derived from GZA9.35, and in MLEC30.1 and MLEC30.2,
which are derived from GZA9.35. Expression of the endogenous FMR1 alleles was shown by mouse-specific RT-PCR (376-bp product). The
reduced intensities of the human RT-PCR signals of GZEC21.4 and GZEC24.16 correspond to the low proportions of cells that retained the
human allele in these clones (see fig. 3A).
Discussion
The majority of full-mutation fragile X patients present
extensive somatic mosaicism, with homogeneity of ex-
pansion sizes among different somatic tissues (Devys et
al. 1992; Wo¨hrle et al. 1992; Rousseau et al. 1994).
Whereas the homogeneity of expansion patterns is a
characteristic feature of mitotic stability of the fully
methylated full-mutation alleles (Wo¨hrle et al. 1993,
1995), somatic mosaicism is assumed to result from un-
stable behavior of these expansions during a very early
developmental window, before they become stabilized in
their individual pattern by yet-unknown mechanisms
(Steinbach et al. 1998). Fully expanded fragile X alleles
have been shown to exist in oocytes of carrier females
(Malter et al. 1997). Therefore, affected males with frag-
ile X may inherit a full-mutation allele that would prob-
ably be mitotically unstable in the undifferentiated em-
bryonic cells. To elucidate the behavior of fragile X
alleles at early embryonic cell proliferation, we intro-
duced segments of human fragile X chromosomes into
the background of PC13 EC cells, by means of microcell
fusion. Using PC13 hybrids as a model system of un-
differentiated embryonic cells, we directly demonstrated
the mitotic instability of fragile X expansions.
Exciting Properties of the PC13 Model System
Our PC13-derived EC hybrids had the typical prop-
erties of undifferentiated embryonic cells. They retained
the indefinite proliferation capacity and the undiffer-
entiated morphology of the host cell line. Upon treat-
ment with retinoic acid, the hybrid cells aggregated to
form embryoid bodies and differentiated into epitheloid
and neuronlike cells. This is the typical response of PC13
cells to retinoic acid upon induction of cell differentia-
tion (Hooper and Slack 1977). Furthermore, the EC hy-
brid cells had the potency to fully demethylate previously
methylated full-mutation fragile X alleles. Full demethyl-
ation of fragile X alleles has not been observed to occur
on any other cellular background or in any other de-
methylation experiment. In our hybrids, demethylation
of previously methylated full-mutation alleles involved
the complete FMR1 promoter region and may be as-
sociated with alterations of chromatin structure (Coffee
et al. 1999).
Fragile X demethylation in EC hybrids was associated
with permanent transcriptional reactivation of previ-
ously inactive FMR1 genes. Demethylation and reacti-
vation has previously been reported to occur upon treat-
ment of dividing cells with de-azacytidine alone or in
combination with trichostatin A (Chiurazzi et al. 1999;
Coffee et al. 1999); however, in striking contrast to our
hybrids, these drugs induced only partial demethylation
and poor reactivation that was not stably maintained
upon cell proliferation.
Destabilization of Full Expansions in the PC13 Model
System
Independent of their original methylation status, all
expanded alleles were mitotically stable in the A9 back-
ground before they were transferred into PC13 EC cells.
In the EC cells, expansions of 330 and 530 CGGs were
found to have changed to different sizes upon clonal cell
proliferation. Mitotic instability of sufficiently large ex-
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Figure 5 Morphology and Southern analysis of A9 hybrids harboring demethylated human fragile X expansions that were retransferred
from EC cells. Microcells were generated from MLEC30.1 and fused to A9 cells. A, Morphology of a hybrid clone (16*). Bar p 100 mm. B,
Isolated clones harboring chromosomes of both murine parents and a human FMR1 gene, analyzed on EcoRI-plus-EagI blots hybridized to
Ox1.9. The results for nine clones, indicated by numbers, are shown. Notably sharp and intense signals of full-mutation fragments with
unmethylated EagI sites were obtained in many clones; for example, 16* (315 CGGs), 22 (265 CGGs), and 24 (280 CGGs). C, One of the A9
hybrids (16*), subcloned to further prove mitotic stability of the expansion. The unmethylated full-mutation allele could be amplified by cloning
(lanes 1–4) and did not experience any significant change of repeat size upon clonal expansion.
pansions was particularly evident from the smeared pat-
tern of expansions obtained upon Southern analysis of
clone MLEC30.1; this instability also was clearly con-
firmed upon subcloning and was shown to occur as a
function of repeat size. Instability of expanded repeats
upon subclonal cell proliferation was indicated by
smeared or diffuse hybridization patterns obtained from
all subclones that harbored expansions of 1240 CGGs.
Single expansions giving a sharp and intense hybridi-
zation band, indicating increased stability, were found
only in subclones harboring shorter repeats.
These findings clearly demonstrate destabilization of
previously stable fragile X full-mutation alleles, but the
patterns of unstable products in the undifferentiated em-
bryonic cells differed from previous expectations. Al-
though a few products of expansions were identified, the
most prominent feature of instability was size reduction
of large expansions. Since the normal endogenous mu-
rine FMR1 alleles were expressed in all EC hybrids, re-
peat-size reductions most likely resulted from contrac-
tion events instead of from subclonal selection (Salat et
al. 2000). As demonstrated by subcloning ofMLEC30.1,
contraction events can create small and apparently sta-
bilized alleles, the repeat sizes of which may correspond
to a premutation or even a normal allele.
When full expansions that were destabilized and de-
methylated in EC hybrids were retransferred to A9, ex-
panded alleles remained unmethylated, but most of
them—independent of expansion size—regained the pre-
vious phenotype of mitotic stability. Repeat destabili-
zation in the PC13 system of undifferentiated embryonic
cells, therefore, is most likely a process that can be re-
versed upon genetic or epigenetic change of the cellular
background. It would be worthwhile to investigate the
behavior of large unstable fragile X expansions in reti-
noic-acid–differentiated EC hybrids, after adaptation of
the culture techniques to allow for proliferation of epi-
thelial cells and neurons.
A previous article (Burman et al. 1999) reported that,
independent of methylation, instability of large ex-
panded repeats occurred only in differentiated cells of
murine origin and that a high degree of stability resulted
in hybrids of “H4D2” cells that were derived from EC
cell line P19. In contrast to our results for PC13, there
was no demethylation of previously fully methylated ex-
pansions and, very unusually, the H4D2 hybrids retained
the potency of permanent proliferation when their mor-
phology changed upon treatment with retinoic acid.
With the A9 and PC13 systems, however, we clearly
demonstrated the opposite—stabilization of previously
unstable expansions in the differentiated murine A9 cells
and destabilization of previously stable expansions in
undifferentiated EC cells. We cannot offer an explana-
tion for the discordant findings of Burman et al. (1999),
which are inconsistent with current knowledge about
fragile X syndrome.
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Results Applied to the Human Fragile X Embryo
Our results are in accordance with the well-known
situation in patients with full-mutation fragile X, in
whom large expanded repeats are stably maintained in
somatic tissues, if hypermethylated, and are supposed to
be mitotically unstable in an early postzygotic—and,
most probably, undifferentiated—stage (Imbert et al.
1998; Steinbach et al. 1998). This justifies application
of the results obtained from our PC13 model system of
undifferentiated cells of embryonic origin to a human
embryo who started as a pre- or a full-mutation zygote.
On the basis of our results, we canmake some interesting
predictions:
Expanded FMR1 alleles received from a carrier moth-
er either will be unmethylated or will become demethyl-
ated in the undifferentiated cells of the early embryo.
When these cells proliferate, the expanded alleles will be
transcriptionally active and mitotically unstable, as has
already been deduced from the high frequency of mosaic
full-mutation patterns established in early fetal life (Tay-
lor et al. 1999). The findings for PC13 EC cells also
predict contraction—rather than expansion—to occur in
the early developmental window of repeat instability.
Therefore, postzygotic expansion of an inherited pre-
mutation to a disease-causing full mutation would be
less likely to occur than contraction of fully expanded
alleles that were generated prezygotically and inherited
by the embryo through an oocyte.
The concept of prezygotic transition of pre- to full-
mutation alleles, followed by frequent postzygotic con-
traction of the inherited, mitotically unstable repeats, is
in accord with the high frequency of somatic mosaicism
in fragile X patients (Rousseau et al. 1994) and with
patterns of somatic mosaicism consisting of amajor frag-
ment accompanied by some larger and many shorter
fragments (e.g., see the report by Wo¨hrle et al. [1995]).
In particular, this concept is not at variance with the
finding that the occurrence of mosaicism with pre- and
full-mutation alleles is independent of the maternal pre-
mutation size (Moutou et al. 1997), whereas transition
to the full mutation is strongly dependent on the size of
the maternal premutation (Heitz et al. 1992; Imbert et
al. 1998).
Role of Methylation in Repeat Stabilization
A role of DNA methylation in the stabilization of
expanded CGG repeats has been proposed previously,
in view of an absolute association of hypermethylation
with stability of fully expanded repeats in human so-
matic cells (Steinbach et al. 1998; Burman et al. 1999).
This association apparently also exists in undifferen-
tiated embryonic cells of murine origin, since suffi-
ciently large unmethylated full expansions were found
to be mitotically unstable in our PC13 hybrids; how-
ever, most fully expanded fragile X repeats, when in-
troduced from human fibroblasts or from a PC13 hy-
brid, gained mitotic stability in the background of
differentiated murine A9 cells regardless of their meth-
ylation status. These findings indicate that methylation
of large expanded CGG repeats—though contributing
significantly to repeat stabilization—would not be an
essential factor and that the primary determinants of
stabilization remain to be identified.
Fragile X Mice
So far, all attempts to generate transgenic mice with
an expanded FMR1 CGG repeat have failed (Bontekoe
et al. 1997; Lavedan et al. 1998). Premutation-sized re-
peats that were introduced into the endogenous FMR1
gene of mouse embryonic stem cells by homologous re-
combination did not expand to a full mutation either
by mitotic instability at stem cell proliferation or upon
transmission from female carrier mice to offspring. As
indicated by our results for EC cells, large expanded
human CGG repeats are, indeed, mitotically unstable in
the background of undifferentiated stem cells of murine
origin; however, mitotic instability may not lead to full
expansion of a premutation allele and may create only
contraction products. The generation of full-mutation
fragile X mice may require the introduction of substan-
tially large human full-mutation alleles into embryonic
stem cells. This will most probably not be achieved by
a conventional replacement strategy.
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